Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

BHP share price rises as Rio-Glencore merger talks put mining giants back in play

BHP share price rises as Rio-Glencore merger talks put mining giants back in play

SYDNEY, Jan 10, 2026, 16:52 AEDT — Market closed BHP Group Ltd (ASX: BHP) shares ended Friday up 0.8% at A$47.72, steadying after a choppy start to the year as miners took in talk of a Rio Tinto-Glencore tie-up. (Yahoo Finance) The deal chatter matters for BHP because it goes straight to scale and copper. Rio and Glencore said they are in talks about a takeover that could create a mining group bigger than BHP, and some investors say it could force rivals to weigh their own options. (Reuters) BHP has its own near-term catalyst. It is due to publish
TG Therapeutics (TGTX) stock drops 7% as JPMorgan healthcare conference nears — what investors watch next

TG Therapeutics (TGTX) stock drops 7% as JPMorgan healthcare conference nears — what investors watch next

New York, January 9, 2026, 15:59 (EST) — Regular session TG Therapeutics (TGTX.O) shares fell about 7% on Friday, reversing an early rise and leaving the biotech near its session low. The stock was down 7% at $28.35 by 3:55 p.m. EST after opening at $30.69 and sliding as low as $28.215. It hit $30.83 earlier in the session. The move comes with the J.P. Morgan Healthcare Conference set to kick off on Monday in San Francisco, a meeting that often pulls in fresh corporate updates and deal chatter in one tight week. The bank’s agenda shows the event runs
Polestar stock drops despite “best year ever” sales; Feb. 18 update is next test

Polestar stock drops despite “best year ever” sales; Feb. 18 update is next test

New York, Jan 9, 2026, 15:56 EST — Regular session Polestar Automotive Holding UK PLC shares fell 5.9% to $20.90 at 3:56 p.m. EST, swinging between $20.81 and $22.35 in Friday’s Nasdaq session. In an SEC filing, the electric-vehicle maker put 2025 retail sales at about 60,119 cars, up 34%, and said fourth-quarter volumes rose 27% to 15,608; it said the figures were preliminary and could be adjusted. CEO Michael Lohscheller called 2025 its “best year ever” for retail volumes and set Feb. 18 for a strategy update; Polestar said a December ADS ratio change — akin to a reverse
Hims & Hers stock slides as Amazon starts selling Novo Nordisk’s new Wegovy pill

Hims & Hers stock slides as Amazon starts selling Novo Nordisk’s new Wegovy pill

New York, Jan 9, 2026, 15:52 EST — Regular session Shares of Hims & Hers Health, Inc (HIMS.N) fell 5.3% to $32.06 on Friday, after Amazon Pharmacy said it now offers Novo Nordisk’s Wegovy weight-loss pill, raising the pressure on telehealth sellers chasing obesity drug demand. The stock hit an intraday high of $34.35 before sliding to a session low of $32.06. (Reuters) The move matters because weight-loss has become a key battleground for online healthcare platforms, and the market has started to treat GLP-1 drugs — medicines that can curb appetite and drive weight loss — as a price
Why iRhythm stock is sliding today as Wall Street looks to JPM Healthcare Conference

Why iRhythm stock is sliding today as Wall Street looks to JPM Healthcare Conference

New York, Jan 9, 2026, 15:54 EST — Regular session Shares of iRhythm Technologies (IRTC.O) fell 3.9% to $181.95 on Friday, after swinging between $190.16 and $179.61 in the session. The stock ended Thursday at $189.25. The drop left iRhythm behind a broader advance in U.S. equities, with S&P 500 and Nasdaq-tracking funds up about 0.8% and 1.1%, respectively. That gap matters because iRhythm trades like a growth stock — sensitive to rate moves and risk appetite — and those currents can swamp stock-specific news for stretches. A Labor Department report showed nonfarm payrolls — a broad count of jobs
Las Vegas Sands stock slides as Macau margin jitters flare — what investors are watching next

Las Vegas Sands stock slides as Macau margin jitters flare — what investors are watching next

New York, January 9, 2026, 15:40 (EST) — Regular session Las Vegas Sands shares were down about 4.3% at $59.25 in afternoon trade on Friday, after touching a session low near $59.18. The drop matters now because Sands is one of the U.S. market’s purest plays on Macau casinos, where small swings in costs and promotions can move profits quickly. Traders have been quick to fade anything that hints at weaker margins going into the next round of quarterly reports. JPMorgan said it had been fielding calls from dozens of investors after shares of Hong Kong-listed Sands China fell 4.5%
Arcutis stock sinks 5% after wild swing as traders eye Fed, FDA clock and earnings

Arcutis stock sinks 5% after wild swing as traders eye Fed, FDA clock and earnings

New York, Jan 9, 2026, 15:46 EST — Regular session Arcutis Biotherapeutics shares slid 5.3% to $28.29 in afternoon trading on Friday, after climbing as high as $30.70 earlier. The stock was last at the session low. The move followed a cooler U.S. payrolls report, which reinforced expectations the Federal Reserve will keep rates steady in coming weeks. High-growth biotech names can swing hard when the rate outlook gets murkier. (Reuters) Broader biotech held up better. The S&P biotech ETF XBI and the iShares Nasdaq Biotechnology ETF IBB were both higher, tracking gains in the S&P 500 and Nasdaq-100 ETFs.
Intuitive Machines (LUNR) stock slides after Stifel downgrade as NASA moon rover decision nears

Intuitive Machines (LUNR) stock slides after Stifel downgrade as NASA moon rover decision nears

New York, January 9, 2026, 15:44 EST — Regular session Intuitive Machines Inc shares were down 3.8% at $18.88 on Friday afternoon, after a choppy session that took the stock from $17.82 to $19.73. About 14.0 million shares changed hands, a heavy day for the name. The slide came after a Stifel downgrade. The firm cut the stock to “hold” from “buy,” even as it raised its price target to $20 from $18. Analyst Jonathan Siegmann said Stifel is seeing “increased nervousness” ahead of NASA’s Lunar Terrain Vehicle decision, which he called “imminent,” and cautioned that politics could complicate the
Deckers Outdoor stock drops as Needham pulls DECK from Conviction List, putting Hoka growth back under a microscope

Deckers Outdoor stock drops as Needham pulls DECK from Conviction List, putting Hoka growth back under a microscope

NEW YORK, January 9, 2026, 15:10 (ET) — Regular session Deckers Outdoor (DECK) shares fell 4.2% on Friday, slipping to $102.85 in afternoon trading after an early pop faded and the stock turned lower. Shares swung between $108.72 and $102.18. The drop landed even as the broader market held firm, a sign traders were treating this as a stock-specific story. A weaker U.S. jobs report pushed investors to price in a longer pause in Federal Reserve rate cuts, a backdrop that can make growth stocks and consumer names twitchy. (Reuters) Needham analyst Tom Nikic on Thursday removed Deckers from the
Why Equity Residential stock is sliding today: BMO downgrade meets a $400 million asset sale

Why Equity Residential stock is sliding today: BMO downgrade meets a $400 million asset sale

New York, Jan 9, 2026, 15:26 EST — Regular session Equity Residential shares were down 3.8% at $60.46 by 3:26 p.m. EST, underperforming the broader apartment REIT group after BMO Capital cut its rating to “market perform” from “outperform.” (StreetInsider.com) The move lands on a day when rates-sensitive sectors were already on edge after fresh U.S. labor data showed payroll growth stayed soft in December and the unemployment rate eased to 4.4%. (Bureau of Labor Statistics) Treasury yields were little changed after the report, with the 10-year hovering around 4.18%, but even small swings in long-term rates can move REIT
Merit Medical (MMSI) stock slides 8% as founder exits chair role and early Q4 revenue lands

Merit Medical (MMSI) stock slides 8% as founder exits chair role and early Q4 revenue lands

NEW YORK, Jan 9, 2026, 14:49 EST — Regular session Merit Medical Systems, Inc. shares were down about 8.1% at $85.66 on Friday afternoon, after the Nasdaq-listed medical device maker released preliminary fourth-quarter revenue and confirmed a change at the top of its board. The stock hit a session low of $84.75. Merit said late Thursday its board appointed longtime director F. Ann Millner as chair, effective Jan. 5, after founder Fred P. Lampropoulos resigned as a director and chair on Jan. 4. The company also projected preliminary unaudited fourth-quarter revenue of about $389 million to $395 million and said
Twilio (TWLO) stock slides as CEO share-sale filing lands; February earnings loom

Twilio (TWLO) stock slides as CEO share-sale filing lands; February earnings loom

NEW YORK, Jan 9, 2026, 15:07 EST — Regular session Twilio shares fell on Friday after a regulatory filing showed Chief Executive Khozema Shipchandler sold stock under a pre-arranged trading plan. The stock was down 3.9% at $132.13, after earlier trading as high as $138.39. The disclosure matters now because Twilio has become a crowded, rate-sensitive software trade again, and investors are quick to react to any signal around insider activity. With the next earnings report weeks away, traders are trying to separate routine selling from a shift in tone ahead of 2026 guidance. The broader market was firmer after
1 353 354 355 356 357 882

Stock Market Today

South32 share price drops 4% in ASX rout — what investors watch before results

South32 share price drops 4% in ASX rout — what investors watch before results

7 February 2026
South32 shares fell 4.1% to A$4.41 Friday as Australian miners dropped in the worst ASX session since April 2025. The S&P/ASX 200 lost 2%, erasing almost A$70 billion in value. South32’s half-year results and interim dividend decision are set for Feb. 12. Markets reopen Monday with investors watching for further volatility.
Wesfarmers share price: what to watch on ASX next week as results loom

Wesfarmers share price: what to watch on ASX next week as results loom

7 February 2026
Wesfarmers shares closed down 1.33% at A$85.04 on Friday, following a sharp drop in the S&P/ASX 200, which fell 2% for its steepest one-day loss in 10 months. Investors are watching for Australia’s household spending data next week and Wesfarmers’ half-year results due Feb. 19.
Go toTop